Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Hypertension program development

Referrals and patient selection

Broaden your approach to hypertension with a highly
focused program that includes the Symplicity™ blood
pressure procedure.

Contact us
Alert Indications, Safety, and Warnings

Why build a hypertension program?

See how the Symplicity blood pressure procedure can help your patients with hypertension.
An 80% icon describes the percentage of people with hypertension worldwide who do not have the condition under control.

of hypertension patients do not have their blood pressure under control.1

A globe icon provides visual context for the fact that hypertension is a major cause of premature death worldwide.

Hypertension is a major cause of premature
death worldwide.1

A data point shows that 50% of hypertension patients become non-adherent to medication within one year.

of hypertension patients become non-adherent to their medication within one year.2

A blood pressure cuff icon supports the idea that physicians should build a dedicated hypertension program.

Building a successful hypertension program allows you to focus your efforts and drive greater change.

Three steps to get started

Here are three steps you can take right now to build or enhance a dedicated hypertension program.
The numeral one represents the first step in the process of building a hypertension program.

Assess the opportunity

Proven to deliver significant blood pressure reductions3, the Symplicity blood pressure procedure expands your ability to treat hypertension.
See the proof
The numeral two represents the second step in the process of building a hypertension program.

Create a care pathway

Promote blood pressure reduction by establishing a comprehensive treatment care pathway that considers global guidelines for the Symplicity blood pressure procedure.
Review guidelines
The numeral three represents the third step in the process of building a hypertension program.

Guide patient choices

Engage and educate patients on hypertension management and control.
Drive patient awareness

Three pillars of hypertension treatment

The two most common pillars of hypertension care are lifestyle modifications and medication. Today, there is another pillar available for treating hypertension: the Symplicity blood pressure procedure.
A biking icon represents lifestyle modfiications for treating hypertension, such as increased exercise.

Lifestyle modifications
improve overall health.

An icon of a pill and tablet represents the anti-hypertensive medications many patients take.

Medications
Help reduce blood pressure.

A kidneys icon refers to the fact that Medtronic Renal Denervation treats the renal nerves to reduce blood pressure.

Symplicity blood pressure procedure
reduces blood pressure in patients who take antihypertensive medication and those who do not.3-6

Learn more about the procedure
A female doctor converses with a male patient while both are seated.

Educate your patients

Use our patient-friendly resources to provide an overview of hypertension, its health risks, and why the Symplicity blood pressure procedure might be the right choice.

Explore patient materials
*

ANCOVA adjusted; secondary efficacy analysis.

†

RDN arm reduction from baseline.

1

World Health Organization. 25 August 2021.

2

Jung O, Gechter JL. Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. Hypertension. 2013;31(4):766-774

3

Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet 2020; Published online March 29, 2020.

4

Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401-1410.

5

Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.

6

Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346-2355.